Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody
Abstract Background Dysregulated production of interleukin (IL)-6 is implicated in the pathology of inflammatory bowel disease (IBD). Neutralization of IL-6 in the gut by safe probiotic bacteria may help alleviate intestinal inflammation. Here, we developed Lactococcus lactis with potent and selecti...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2022-07-01
|
| Seria: | Microbial Cell Factories |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12934-022-01873-7 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|